Latest Talk
DIA QPPV Talks Webinar
This 45-minute on-demand webinar provides an exclusive preview of the DIA Global Forum for Qualified Persons for Pharmacovigilance (QPPV). The session features two expert speakers who delve into critical topics in pharmacovigilance. Ilaria Grisoni, Executive Director, Head of EU/International PV & Global Risk Management and EEA at Gentium Srl (a Jazz Pharmaceuticals Company), discussed strategies…
On-demand Talks
![[DIA Europe 2024] Drug Repurposing: Opportunities & Challenges](https://cdn.brighttalk.com/ams/california/images/communication/620600/image_993010.png?width=640&height=360)
![[DIA Europe 2024] How to Build a Sustainable Pharmacovigilance Ecosystem?](https://cdn.brighttalk.com/ams/california/images/communication/620595/image_992991.png?width=640&height=360)
![[DIA Europe 2024] HTA Townhall – Ready for 2025 EU Joint Clinical Assessment](https://cdn.brighttalk.com/ams/california/images/communication/620168/image_992140.png?width=640&height=360)
![[DIA Europe 2024] Environment, Equity and Future-Proofing in Healthcare Systems](https://cdn.brighttalk.com/ams/california/images/communication/620167/image_992134.png?width=640&height=360)
![[DIA Europe 2024] Preference Studies in Regulatory and Payers' Decisions](https://cdn.brighttalk.com/ams/california/images/communication/619777/image_992126.png?width=640&height=360)
![[DIA Europe 2024] Impact of the New Pharma Legislation on Regulatory Operations](https://cdn.brighttalk.com/ams/california/images/communication/619771/image_991142.png?width=640&height=360)
![[DIA Europe 2024] Reimagining Labelling E2E Process: EU Centralised Procedure](https://cdn.brighttalk.com/ams/california/images/communication/619722/image_991060.png?width=640&height=360)
Related topics: